Showing 1 - 2 results of 2 for search 'A. Yu. Zaritskiy', query time: 0.01s Refine Results
  1. 1
    Efficacy and safety of tyrosine kinase inhibitors (dasatinib, nilotinib) in the treatment of chronic phase chronic myeloid leukemia

    Efficacy and safety of tyrosine kinase inhibitors (dasatinib, nilotinib) in the treatment of chronic phase chronic myeloid leukemia by E. G. Lomaia, E. G. Romanova, E. I. Sbityakova, A. Yu. Zaritskiy

    Published 2014-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    CLINICAL AND LABORATORY FEATURES OF ESSENTIAL THROMBOCYTOSIS AND PRIMARY MYELOFIBROSIS DEPENDING ON JAK2 AND CALR1 MUTATION STATUS

    CLINICAL AND LABORATORY FEATURES OF ESSENTIAL THROMBOCYTOSIS AND PRIMARY MYELOFIBROSIS DEPENDING ON JAK2 AND CALR1 MUTATION STATUS by E. G. lisina, N. T. Siordiya, P. A. Butylin, A. A. Silyutina, N. M. Matyukhina, O. M. Senderova, E. S. Fokina, V. A. Ovsepyan, E. G. Lomaia, A. Yu. Zaritskiy

    Published 2017-10-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: